Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Lipidomics datasets of human cirrhotic liver

ABSTRACT: Mass spectrometry-based lipidomics datasets of cirrhotic liver tissue from patients with advanced steatotic liver disease (SLD; N=20) compared with background liver tissue (N=32) from patients with colorectal metastases to the liver (CRLM) or focal nodular hyperplasia (FNH). RAW datafiles were centroided and converted using MSConvert to mzXML format.

INSTRUMENT(S): LTQ Orbitrap Elite

ORGANISM(S): Homo Sapiens (ncbitaxon:9606)

SUBMITTER: Zoe Hall

PROVIDER: MSV000093530 | MassIVE | Wed Nov 29 03:47:00 GMT 2023

REPOSITORIES: MassIVE

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

Lipidomics datasets of mouse prostate cancer with AMPK activation

Project description:Lipidomics was performed on prostate tissue from mice aged 17 weeks: WT, Pten-/- and Pten-/- with AMPK gain of function mutation (n=4 per genotype). Lipidomics was also performed on xenograft tissue from mice treated with either Vehicle (n=3) or BI9774 (n=4) to pharmacologically activate AMPK. RAW datafiles were centroided and converted using MSConvert to mzXML format.

2023-03-03 | MSV000091405 | MassIVE

GNPS - Lipidomics datasets of mouse prostate cancer with AMPK activation

2023-03-03 | MSV000091405 | GNPS

E-GEOD-50760

Project description:RNA-seq of 54 samples (normal colon, primary tumor, and liver metastases) from 18 colorectal cancer patients

2025-01-24 | E-GEOD-50760 | ExpressionAtlas

Proteome and Phosphoproteome of colorectal cancer liver metastases (CRLM), phosphoproteomics of AZD6482 treated CRC cell lines, phosphoproteomics of copanlisib treated xenograft

Project description:The research focuses on the longitudinal analysis of phosphoproteomic profiles in patients with recurrent colorectal liver metastases. Twenty-four individuals who underwent initial and recurrent resections for colorectal liver metastases participated in the study. Tissue samples were systematically collected throughout the treatment period from the liver metastases and normal liver tissue of each of the 24 patients at two timepoints. To validate the therapeutic candidate, we conducted a phosphoproteomics analysis of cell lines treated with AZD6482 and xenograft samples treated with copanlisib. The analysis aimed to assess the pharmacological effects of these treatments.

2025-01-30 | PXD048988 | JPOST Repository

E-GEOD-83148

Project description:Expression data of HBV infected liver tissue

2025-01-24 | E-GEOD-83148 | ExpressionAtlas

E-GEOD-49541

Project description:Expression data for Nonalcoholic fatty liver disease patients

2025-01-24 | E-GEOD-49541 | ExpressionAtlas

E-PROT-69

Project description:76 human liver tissue proteomes by PCT-SWATH

2022-01-26 | E-PROT-69 | ExpressionAtlas

E-GEOD-57803

Project description:Gene Expression Signature in Adipose Tissue of Acromegaly Patients

2025-01-24 | E-GEOD-57803 | ExpressionAtlas

E-GEOD-19280

Project description:Transcription profiling by array of normal pancreas, primary pancreatic ductal adenocarcinoma (PDAC), normal liver, and pancreatic liver metastases using the Affymetrix HG-U133B array

2025-01-24 | E-GEOD-19280 | ExpressionAtlas

E-GEOD-19279

2025-01-24 | E-GEOD-19279 | ExpressionAtlas